Trade IHH - Q0Fsg CFD

Add to favourite

1.7246

0.58%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.0208

Long position overnight fee

-0.020345%

Short position overnight fee

-0.001573%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

SGD

Margin

Stock exchange

Singapore

Commission on trade

*Information provided by Capital.com

IHH Healthcare Bhd ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	1.7147
Open*	1.7246
1-Year Change*	N/A
Day's Range*	1.7246 - 1.7346
52 wk Range	5.53-6.15
Average Volume (10 days)	3.67M
Average Volume (3 months)	79.00M
Market Cap	52.49B
P/E Ratio	21.73
Shares Outstanding	8.81B
Revenue	20.50B
EPS	0.27
Dividend (Yield %)	1.1745
Beta	0.64
Next Earnings Date	Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 19, 2024	1.7246	0.0000	0.00%	1.7246	1.7346	1.7246
Apr 18, 2024	1.7147	0.0000	0.00%	1.7147	1.7246	1.7147
Apr 17, 2024	1.7246	0.0099	0.58%	1.7147	1.7246	1.7147
Apr 16, 2024	1.7047	0.0000	0.00%	1.7047	1.7246	1.7047
Apr 15, 2024	1.7147	0.0100	0.59%	1.7047	1.7246	1.7047
Apr 11, 2024	1.7147	0.0100	0.59%	1.7047	1.7147	1.7047
Apr 9, 2024	1.7147	0.0000	0.00%	1.7147	1.7246	1.7147
Apr 8, 2024	1.7147	0.0000	0.00%	1.7147	1.7147	1.7147
Apr 5, 2024	1.7147	0.0100	0.59%	1.7047	1.7147	1.7047
Apr 4, 2024	1.7147	0.0000	0.00%	1.7147	1.7147	1.7047
Apr 3, 2024	1.7147	0.0100	0.59%	1.7047	1.7147	1.7047
Apr 2, 2024	1.7147	0.0000	0.00%	1.7147	1.7246	1.7147
Apr 1, 2024	1.7246	0.0099	0.58%	1.7147	1.7246	1.7147
Mar 28, 2024	1.7047	0.0000	0.00%	1.7047	1.7047	1.7047
Mar 27, 2024	1.7047	-0.0100	-0.58%	1.7147	1.7147	1.7047
Mar 26, 2024	1.7147	0.0100	0.59%	1.7047	1.7246	1.6748
Mar 25, 2024	1.7047	0.0100	0.59%	1.6947	1.7047	1.6848
Mar 22, 2024	1.7047	0.0000	0.00%	1.7047	1.7047	1.6947
Mar 21, 2024	1.6947	0.0000	0.00%	1.6947	1.7047	1.6947
Mar 20, 2024	1.6947	-0.0200	-1.17%	1.7147	1.7147	1.6947

IHH Events

Time (UTC)	Country	Event
Wednesday, May 29, 2024
Time (UTC) 02:00	Country MY	Event IHH Healthcare Bhd Annual Shareholders Meeting IHH Healthcare Bhd Annual Shareholders Meeting Forecast - Previous -
Time (UTC) 08:00	Country MY	Event Q1 2024 IHH Healthcare Bhd Earnings Release Q1 2024 IHH Healthcare Bhd Earnings Release Forecast - Previous -
Tuesday, August 27, 2024
Time (UTC) 08:00	Country MY	Event Q2 2024 IHH Healthcare Bhd Earnings Release Q2 2024 IHH Healthcare Bhd Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	17988.7	17131.8	13404.6	14912.5	11520.9
Revenue	17988.7	17131.8	13404.6	14912.5	11520.9
Cost of Revenue, Total	5497.55	5137.12	4096.35	4507.6	3159.17
Gross Profit	12491.1	11994.6	9308.26	10404.9	8361.76
Total Operating Expense	15266.4	14071.9	12150.8	13171.6	9978
Selling/General/Admin. Expenses, Total	6452.1	6240.72	5375.6	5456.12	4872.39
Depreciation / Amortization	1408.45	1314.9	1389.63	1353.99	935.439
Unusual Expense (Income)	-80.144	169.296	7.687	64.191	3.719
Other Operating Expenses, Total	1988.47	1209.83	1281.5	1789.69	1007.27
Operating Income	2722.25	3059.91	1253.85	1740.89	1542.94
Interest Income (Expense), Net Non-Operating	-463.603	-466.067	-647.869	-641.93	-752.114
Other, Net	-41.556	-38.103	-38.474	-56.239	-38.353
Net Income Before Taxes	2217.09	2555.74	567.507	1042.72	752.47
Net Income After Taxes	1645.14	2176.58	205.846	514.842	489.86
Minority Interest	-96.744	-314.06	83.036	36.634	137.827
Net Income Before Extra. Items	1548.4	1862.53	288.882	551.476	627.687
Net Income	1548.4	1862.53	288.882	551.476	627.687
Income Available to Common Excl. Extra. Items	1496.19	1774.22	199.039	463.304	541.841
Income Available to Common Incl. Extra. Items	1496.19	1774.22	199.039	463.304	541.841
Diluted Net Income	1496.19	1774.22	199.039	463.304	541.841
Diluted Weighted Average Shares	8804.3	8782.73	8775.95	8774.63	8292.11
Diluted EPS Excluding Extraordinary Items	0.16994	0.20201	0.02268	0.0528	0.06534
Dividends per Share - Common Stock Primary Issue	0.07	0.06	0.04	0.04	0.03
Diluted Normalized EPS	0.17306	0.19222	0.03035	0.06826	0.06545
Total Adjustments to Net Income	-52.212	-88.3	-89.843	-88.172	-85.846

	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022
Total revenue	4673.9	5142.41	4856.81	4595.24	4373.57
Revenue	4673.9	5142.41	4856.81	4595.24	4373.57
Cost of Revenue, Total	1440.02	1507.49	1472.28	1402.48	1381.65
Gross Profit	3233.88	3634.92	3384.54	3192.76	2991.92
Total Operating Expense	3934.49	3210.88	4459.96	3885.28	3447.19
Selling/General/Admin. Expenses, Total	1697.87	1933.32	1693.13	1629.19	1557.92
Depreciation / Amortization	337.647	369.415	748.795	349.832	382.338
Other Operating Expenses, Total	499.967	-434.581	722.527	493.983	420.827
Operating Income	739.406	1931.53	396.857	709.967	926.377
Interest Income (Expense), Net Non-Operating	-185.394	-124.938	-185.589	-191.387	-26.612
Other, Net	-12.021	-14.08	-7.091	-5.323	-21.256
Net Income Before Taxes	541.991	1792.51	204.177	513.257	878.509
Net Income After Taxes	384.924	1551.96	16.43	324.283	734.369
Minority Interest	-83.092	-161.445	174.843	-72.521	-122.265
Net Income Before Extra. Items	301.832	1390.52	191.273	251.762	612.104
Net Income	301.832	1390.52	191.273	251.762	612.104
Total Adjustments to Net Income	0	0	0	-6.983	-23.206
Income Available to Common Excl. Extra. Items	301.832	1390.52	191.273	244.779	588.898
Income Available to Common Incl. Extra. Items	301.832	1390.52	191.273	244.779	588.898
Diluted Net Income	301.832	1390.52	191.273	244.779	588.898
Diluted Weighted Average Shares	8807	8806.28	8806.14	8805.64	8807.24
Diluted EPS Excluding Extraordinary Items	0.03427	0.1579	0.02172	0.0278	0.06687
Dividends per Share - Common Stock Primary Issue	0.035	0	0.07	0	0
Diluted Normalized EPS	0.03049	0.04489	0.04857	0.0286	0.03799
Unusual Expense (Income)	-41.012	-164.758	-176.765	9.795	-295.542

Annual
Quarterly

	2022	2021	2020	2019	2018
Total Current Assets	8282.32	8533.05	7345.94	7626.33	10535.8
Cash and Short Term Investments	3912.61	5358.41	4610.4	5058.95	8110.58
Cash	1345.87	1516.68	1402.44	1787.09	4166.13
Short Term Investments	249.717	340.733	422.593	344.283	347.185
Total Receivables, Net	2418.75	2276.82	1794.41	1963.57	1834.33
Accounts Receivable - Trade, Net	2206.94	2153.95	1640.84	1849.51	1699.01
Total Inventory	595.902	528.927	510.236	434.534	431.458
Prepaid Expenses	188.825	119.002	115.74	102.945	88.26
Other Current Assets, Total	1166.24	249.891	315.15	66.326	71.159
Total Assets	48467.5	45510.3	44534.3	45053.3	45020.9
Property/Plant/Equipment, Total - Net	18567.8	17369.9	18181.6	17932.3	14123.3
Property/Plant/Equipment, Total - Gross	28624.9	25264.6	25676.2	24195.3	20149.5
Accumulated Depreciation, Total	-10057.1	-7894.72	-7494.53	-6263	-6026.19
Goodwill, Net	13209.4	12170.7	12123.1	12574.7	11829.2
Intangibles, Net	2737.84	2022.63	1990.43	2081.27	2256.88
Long Term Investments	4205.78	4115.39	3942.07	3859.93	4411.05
Note Receivable - Long Term	389.308	322.472	327.725	424.865	333.89
Other Long Term Assets, Total	1075.07	976.116	623.354	553.904	1530.74
Total Current Liabilities	7258.73	6049.26	5615.07	5349.23	5518.07
Accounts Payable	1742.85	1515.29	1249.07	1348.55	1428
Accrued Expenses	1352.68	1258.12	973.045	1020.91	1134.45
Notes Payable/Short Term Debt	44.135	24.229	22.401	121.814	81.215
Current Port. of LT Debt/Capital Leases	1815.91	1456.06	1237.61	860.2	1123.11
Other Current Liabilities, Total	2303.15	1795.55	2132.94	1997.76	1751.3
Total Liabilities	22275.5	20927	20636.4	20555.6	20868.9
Total Long Term Debt	8973.91	9393.39	10368.8	10117.6	9366.38
Long Term Debt	7565.99	7609.49	8664.68	8266.07	9225.25
Capital Lease Obligations	1407.92	1783.9	1704.08	1851.57	141.131
Deferred Income Tax	1648.53	1234.67	1168.26	1110	982.333
Minority Interest	2967.08	2693.54	3137.49	3596.27	4199.75
Other Liabilities, Total	1427.27	1556.12	346.808	382.459	802.37
Total Equity	26192	24583.3	23897.9	24497.7	24151.9
Common Stock	19684.9	19614.9	19473.4	19455.1	19427.6
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)	2725.58	1296.63	613.266	841.494	417.309
Unrealized Gain (Loss)	83.434	83.434	83.434	83.434	85.89
Other Equity, Total	3698.09	3588.31	3727.82	4117.63	4221.16
Total Liabilities & Shareholders’ Equity	48467.5	45510.3	44534.3	45053.3	45020.9
Total Common Shares Outstanding	8806.04	8796.72	8777.22	8773.99	8769.3
Cash & Equivalents	2317.02	3501	2785.36	2927.58	3597.27

	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022
Total Current Assets	8049.04	8973.12	8282.32	7563.35	8406.54
Cash and Short Term Investments	3790.23	5070.4	3912.61	3676.07	4465.43
Cash	1378.68	2534.5	1345.87	1126.34	1497.32
Cash & Equivalents	2219.76	2387.83	2317.02	2289.62	2796.73
Short Term Investments	191.776	148.068	249.717	260.114	171.383
Total Receivables, Net	3124.73	3039.73	2699.06	2492.21	2491.38
Accounts Receivable - Trade, Net	3084.7	2957.45	2625.42	2422.35	2439.61
Total Inventory	668.871	665.361	595.902	599.273	584.418
Other Current Assets, Total	465.213	197.63	1074.75	795.794	865.319
Total Assets	49783.6	50564.8	48467.5	48361	48514.2
Property/Plant/Equipment, Total - Net	19151	19111.4	18567.8	19145.8	18832.8
Goodwill, Net	14197.5	13924.3	13209.4	13322.6	13152.6
Intangibles, Net	2703.68	2849.27	2737.84	2765.09	2649.59
Long Term Investments	4342.77	4349.33	4205.78	4097.3	3903.19
Note Receivable - Long Term	576.987	558.429	571.468	501.153	519.091
Other Long Term Assets, Total	762.684	798.928	892.913	965.797	1050.31
Total Current Liabilities	8263.57	7816.26	7258.73	6290.63	6148.21
Payable/Accrued	5120.27	4775.53	4208.47	3970.55	3983.09
Accrued Expenses	146.94	148.875	148.47	149.616	135.859
Notes Payable/Short Term Debt	86.9	51.834	44.135	63.064	54.826
Current Port. of LT Debt/Capital Leases	2457.95	2402.38	1815.91	1507.4	1389.53
Other Current Liabilities, Total	451.519	437.635	1041.74	600.009	584.896
Total Liabilities	22271.8	22746.4	22275.5	22235	20772.9
Total Long Term Debt	8337.42	8616.07	8973.91	9631.62	8437.06
Long Term Debt	7021.58	7191.65	7565.99	7917.49	6678.24
Capital Lease Obligations	1315.84	1424.42	1407.92	1714.14	1758.82
Deferred Income Tax	1689.91	1763.74	1648.53	1644.93	1629.44
Minority Interest	3393.8	3140.51	2967.08	3202.54	3230.29
Other Liabilities, Total	587.059	1409.85	1427.27	1465.27	1327.89
Total Equity	27511.9	27818.4	26192	26126	27741.3
Common Stock	19691.6	19691.6	19684.9	19684.9	19661.7
Retained Earnings (Accumulated Deficit)	2925.53	3491.58	2725.58	2618.12	2325.37
Unrealized Gain (Loss)	83.434	83.434	83.434	83.434	83.434
Other Equity, Total	4811.26	4551.77	3698.09	3739.61	5670.82
Total Liabilities & Shareholders’ Equity	49783.6	50564.8	48467.5	48361	48514.2
Total Common Shares Outstanding	8806.99	8806.99	8806.04	8806.04	8802.78

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	2217.09	2555.74	567.507	1042.72	752.47
Cash From Operating Activities	3813.72	3531.88	2444.8	2447.49	1864.26
Cash From Operating Activities	1732.37	1436.94	1339.41	1289.86	876.982
Amortization	58.452	47.251	57.899	65.629	58.457
Non-Cash Items	220.472	221.78	1033.13	1148.65	653.522
Cash Taxes Paid	616.132	490.316	330.166	575.449	380.08
Cash Interest Paid	293.706	303.118	340.054	391.896	363.147
Changes in Working Capital	-414.666	-729.831	-553.155	-1099.38	-477.173
Cash From Investing Activities	-1853.89	-821.69	-2077.83	-2594.18	-3228.41
Capital Expenditures	-1668.4	-1027.4	-874.241	-1055.56	-1046.73
Other Investing Cash Flow Items, Total	-185.495	205.712	-1203.58	-1538.62	-2181.68
Cash From Financing Activities	-2919.85	-1792.89	-860.058	-2915.14	928.388
Financing Cash Flow Items	-2793.08	-621.578	-604.813	-1332.85	-651.803
Total Cash Dividends Paid	-528.162	-351.163	-350.96	-263.22	-247.338
Issuance (Retirement) of Stock, Net	55.742	103.19	0.626	101.583	12.642
Issuance (Retirement) of Debt, Net	345.65	-923.335	95.089	-1420.65	1814.89
Foreign Exchange Effects	-371.069	-91.478	115.669	-7.274	68.583
Net Change in Cash	-1331.1	825.823	-377.416	-3069.1	-367.183

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Net income/Starting Line	1792.51	2217.09	2012.91	1499.66	621.148
Cash From Operating Activities	660.985	3813.72	2948.92	1695.37	464.427
Cash From Operating Activities	358.274	1732.37	1006.81	668.965	299.616
Amortization	11.141	58.452	35.216	23.228	10.239
Non-Cash Items	-970.885	220.472	60.267	-171.502	81.948
Cash Taxes Paid	114.445	616.132	501.461	306.105	96.7
Cash Interest Paid	102.768	293.706	235.918	133.72	56.889
Changes in Working Capital	-530.053	-414.666	-166.286	-324.98	-548.524
Cash From Investing Activities	815.751	-1853.89	-1453.06	-639.141	-285.143
Capital Expenditures	-256.08	-1668.4	-1258.53	-780.371	-303.648
Other Investing Cash Flow Items, Total	1071.83	-185.495	-194.532	141.23	18.505
Cash From Financing Activities	-213.205	-2919.85	-2909.42	-1687.08	-261.667
Financing Cash Flow Items	-204.164	-2608.23	-2550.44	-240.551	-149.1
Issuance (Retirement) of Debt, Net	-14.53	345.65	279.234	-955.218	-148.968
Foreign Exchange Effects	-54.738	-371.069	-196.129	-10.376	11.896
Net Change in Cash	1208.79	-1331.1	-1609.7	-641.225	-70.487
Total Cash Dividends Paid		-713.016	-693.957	-528.162
Issuance (Retirement) of Stock, Net	5.489	55.742	55.742	36.855	36.401

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

IHH Company profile

About IHH Healthcare Bhd

IHH Healthcare Berhad is a Malaysia-based international healthcare services provider. The Company manages a portfolio of trusted healthcare brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai, Parkway and IMU in its key markets of Malaysia, Singapore, Turkey, India and Greater China (including Hong Kong). The Company operates through five segments: Parkway Pantai, which is a hospital operator and healthcare service provider in Asia; Acibadem Holdings, which is a hospital operator and healthcare service provider in Central Eastern Europe, the Middle East and North Africa and investment holding companies owning Acibadem Saglik Yatirimlari Holding A.S. (ASYH); IMU Health, which is an education service provider in Malaysia; PLife REIT, which is a real estate investment trust, and others segment, which includes the corporate office. The Company operates approximately 80 hospitals in over 10 countries.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, IHH Healthcare Bhd revenues increased 28% to RM17.13B. Net income applicable to common stockholders increased from RM199M to RM1.77B. Revenues reflect Parkway Pantai segment increase of 30% to RM12.37B, Acibadem Holdings segment increase of 26% to RM4.35B, Singapore segment increase of 30% to RM5.03B, India segment increase of 40% to RM3.73B.

Industry:

Hospitals, Clinics & Primary Care Services

Level 11 Block A
Pantai Hospital Kuala Lumpur
KUALA LUMPUR
WILAYAH PERSEKUTUAN 59100
MY

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024